1-855-378-42281-855-378-4228
One of the out-patient treatment options for individuals in Blackstone who are struggling with opioid dependence and addiction is opioid maintenance therapy. Licensed clinics and doctors are certified to administer specific medications to opioid addicted individuals, many of which are opioid-based also and are addictive. With low enough amounts the individual does not experience being high but also does not have severe cravings and isn't experiencing opioid withdrawal. Methadone is the first drug tried for this sole purpose, but there are a few more options currently to choose from.
Methadone is an opiate and is meant to be taken at an outpatient medical center licensed to dispense the drug, that is taken daily in liquid or pill form. The price of the med is approximately under $200 per month. Buprenorphine is also an opiate based med, and is a pill often taken every other day. But different from Methadone that can only be administered in structured medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is approximately $300 a month for the generic of the med. There is also a type of buprenorphine that contains the ingredient naloxone, which is a drug that reverses the effects of opiates. A person consuming this formulation, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It too is taken every day, and is priced about $450 monthly. Naltrexone is an additional med taken in opioid maintenance therapy, but unlike the other drugs aforementioned it's an opioid blocker and is not an opioid. There is an option to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents a person from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 monthly.
For All Alcohol and Drug Rehab Centers In Blackstone, Click Here.
